retatrutide ly3437943 clinical trial Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Retatrutide: Phase 3 Results (Up

Upon recognition of MSU crystals, the NLRP3 inflammasome is activated, leading to the cleavage of pro-inflammatory cytokines, specifically interleukin-1 (IL-1) and interleukin-18 (IL-18)

Quick Answer: GLP-1s and Heart Health GLP-1 medications may support heart health indirectly by helping appropriate patients lose excess weight, improve blood sugar control, reduce visceral fat, and improve cardiometabolic markers such as blood pressure, triglycerides, waist circumference, and inflammation

Evidence for a beneficial impact of telehealth on achieving treatment goals in those living with type 2 diabetes is growing [333, 334]

Sixty percent gone